These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 8207529
1. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y. J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529 [Abstract] [Full Text] [Related]
2. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y. Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400 [Abstract] [Full Text] [Related]
3. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. Nakada M, Kita D, Futami K, Yamashita J, Fujimoto N, Sato H, Okada Y. J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952 [Abstract] [Full Text] [Related]
4. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J. J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276 [Abstract] [Full Text] [Related]
6. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements. Yokohama Y, Matsumoto T, Hirakawa M, Kuroki Y, Fujimoto N, Imai K, Okada Y. Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853 [Abstract] [Full Text] [Related]
7. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Iwata H, Kobayashi S, Iwase H, Masaoka A, Fujimoto N, Okada Y. Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524 [Abstract] [Full Text] [Related]
8. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Lampert K, Machein U, Machein MR, Conca W, Peter HH, Volk B. Am J Pathol; 1998 Aug; 153(2):429-37. PubMed ID: 9708803 [Abstract] [Full Text] [Related]
10. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Kachra Z, Beaulieu E, Delbecchi L, Mousseau N, Berthelet F, Moumdjian R, Del Maestro R, Béliveau R. Clin Exp Metastasis; 1999 Aug; 17(7):555-66. PubMed ID: 10845554 [Abstract] [Full Text] [Related]
17. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix. Davidson B, Goldberg I, Liokumovich P, Kopolovic J, Gotlieb WH, Lerner-Geva L, Reder I, Ben-Baruch G, Reich R. Int J Gynecol Pathol; 1998 Oct; 17(4):295-301. PubMed ID: 9785129 [Abstract] [Full Text] [Related]
18. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y. Int J Cancer; 1996 Feb 20; 69(1):9-16. PubMed ID: 8600068 [Abstract] [Full Text] [Related]
19. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Ito A, Nakajima S, Sasaguri Y, Nagase H, Mori Y. Br J Cancer; 1995 May 20; 71(5):1039-45. PubMed ID: 7734296 [Abstract] [Full Text] [Related]
20. Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: effects of taxol. Stearns ME, Wang M. Oncol Res; 1994 May 20; 6(4-5):195-201. PubMed ID: 7841542 [Abstract] [Full Text] [Related] Page: [Next] [New Search]